Evaluation of the Effects of Methamphetamine on Amniotic Sac Composition in Pregnant Mice and Their Offspring

Subject Areas : Journal of Animal Biology

Milad  Rezazadeh ¹ (Department of Biology, Islamic Azad University, North Tehran Branch, Tehran, Iran)
Ramin  Hajikhani ² (Department of Biology, Islamic Azad University, North Tehran Branch, Tehran, Iran)
Gholamhassan  Vaezi ³ (Department of Biology, Islamic Azad University, Damghan Branch, Damghan, Iran)
Maryam  Bananej ⁴ (Department of Biology, Islamic Azad University, Karaj Branch, Karaj, Iran)

Received: 2021-07-02 Accepted : 2021-08-05 Published : 2022-05-22

Keywords: Ovary, Methamphetamine, Amniotic Fluid, Hematoxylin – Eosin,

Abstract :

Methamphetamine is a central nervous system stimulant drug that has become very popular among adolescents and young people in recent years. Since the use of drugs including methamphetamine can have a potential effect on amniotic fluid, expression of genes can affect mother and fetus, tissues, hormones, and other factors, this study was aimed at investigating the effects of methamphetamine on the amniotic sac of pregnant rat and its effects on subsequent generations. In this study, 60 adult Wistar female rats were assigned to six groups: control group, sham group, group receiving 1 mg/kg amphetamine, group receiving 2 mg/kg amphetamine, group receiving 3 mg/kg amphetamine, and group receiving 4 mg/kg amphetamine. At the end of the experimental period, blood samples were taken from the hearts of mice and the desired parameters (testosterone, glucose, LH, FSH, AST, ALT, WBC, and RBC) were measured. The rats were then dissected; amniotic fluid was isolated to evaluate the amount of protein, carbohydrates, fats, phospholipids, and urea. Intraperitoneal injection of methamphetamine caused significant changes in the amount of biochemical parameters measured such as LH, T.G, and testosterone compared to the control group. In addition, methamphetamine did not alter FSH. With increasing methamphetamine dose, expression of HOX and TUBB8 genes decreased. The results of this study show that even at low doses, methamphetamine injection increases or decreases ovarian activity and ovogenesis, resulting in impaired ovulation quality and oocyte maturation.

References:

1. Bravo J., Barrio G., De La Fuente L., Royuela L., Domingo L., and Silva T., 2003. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction, 98(6): 749-760.


2. Buchanan D., Tooze J. A., Shaw S., Kinzly M., Heimer R., and Singer M., 2006. Demographic, HIV risk behavior, and health status characteristics of “crack” cocaine injectors compared to other injection drug users in three New England cities. Drug and Alcohol Dependence, 81(3): 221-229.


3. Cheng Y., Sherman S.G., Srirat N., Vongchak T., Kawichai S., Jittiwutikarn J., Celentano D.D., 2006. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduction Journal, 3(1): 1-8.


4. Chiang S.C., Chen S.J., Sun H. J., Chan H. Y., and Chen W.J., 2006. Heroin use among youths incarcerated for illicit drug use: psychosocial environment, substance use history, psychiatric comorbidity, and route of administration. American Journal on Addictions, 15(3): 233-241.


5. Crofts N., Louie R., Rosenthal D., and Jolley D., 1996. The first hit: circumstances surrounding initiation into injecting. Addiction, 91(8): 1187-1196.


6. Frery N., Nessmann C., Girard F., Lafond J., Moreau T., Blot P., and Huel G., 1993. Environmental exposure to cadmium and human birthweight. Toxicology, 79(2): 109-118.


7. Fuller C.M., Vlahov D., Ompad D.C., Shah N., Arria A., and Strathdee S.A., 2002. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug and Alcohol Dependence, 66(2): 189-198.


8. Golub A., Johnson B.D., 2001. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. American Journal of Public Health, 91(2): 225.


9. Hatami H., khajehnasiri N., 2015. The effect of intraperitoneally injection of crystal meth on pituitary-gonad axis in adult male rats. Yafteh, 17 (2): 81-89.


10. Hunt N., Griffiths P., Southwell M., Stillwell G., Strang J., 1999. Preventing and curtailing injecting drug use: A review of opportunities for developing and delivering'route transition interventions'. Drug and Alcohol Review, 18(4): 441-451.


11. Islam S.K.N., Hossain K., and Ahsan M., 2000. Sexual life style, drug habit and socio-demographic status of drug addicts in Bangladesh. Public Health, 114(5): 389-392.


12. Kelley M.S., Chitwood D.D., 2004. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection? Social Science and Medicine, 58(10): 2083-2092.


13. Kippler M., Hoque A.W., Raqib R., Öhrvik H., Ekström E.C., and Vahter M., 2010. Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus. Toxicology Letters, 192(2): 162-168.


14. Kosanovic M., Jokanovic M., Jevremovic M., Dobric S., and Bokonjic D., 2002. Maternal and fetal cadmium and selenium status in normotensive and hypertensive pregnancy. Biological Trace Element Research, 89(2): 97-103.


15. Ministry of Health and Medical Education., 2002. HIV/AIDS in Iran. Tehran: Deputy of Health.


16. Mirahmadizadeh A.R., 2007. Study of effectiveness of substance abuse prevention program among military garrison's conscripts in Fars province. Iranian research center for substance abuse and University of Welfare and Rehabilitation Sciences, 14-65.


17. Mojtahedi S., Shabkhiz F., Ravasi A.A., Rosenkranz S., Soori R., Soleimani M., and Tavakoli R., 2020. Voluntary wheel running promotes improvements in biomarkers associated with neurogenic activity in adult male rats. Biochemical and Biophysical Research Communications, 533(4): 1505-1511.


18. Mokri A., 2002. Brief overview of the status of drug abuse in Iran, Archives of Iranian Medicine, 5(3):184-190.


19. Neaigus A., Miller M., Friedman S.R., Hagen D.L., Sifaneck S.J., Ildefonso G., and Des Jarlais D.C., 2001. Potential risk factors for the transition to injecting among non‐injecting heroin users: a comparison of former injectors and never injectors. Addiction, 96(6): 847-860.


20. Newton T.F., Cook I.A., Kalechstein A.D., Duran S., Monroy F., Ling W., and Leuchter A.F., 2003. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical neurophysiology, 114(3): 410-415.


21. Nordahl T.E., Salo R., and Leamon M., 2003. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. The Journal of neuropsychiatry and clinical neurosciences, 15(3): 317-325.


22. Raheb G., Khaleghi E., Moghanibashi-Mansourieh A., Farhoudian A., and Teymouri R., 2016. Effectiveness of social work intervention with a systematic approach to improve general health in opioid addicts in addiction treatment centers. Psychology Research and Behavior Management, 9: 309–315.


23. Rangwala Z., 2014. Hypotension in Chronic Methamphetamine User. In Clinical Anesthesiology. Springer, 187-191


24. Razzaghi E, Rahimi Movaghar A., 2003. Rapid Assessment and Response (RAR), Tehran: World Health Organization, 9- 20.


25. Razzaghi E.M., Movaghar A.R., Green T.C., and Khoshnood K., 2006. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal, 3(1): 1-13.


26. Richards C.F., Clark R.F., Holbrook T., and Hoyt D.B., 1995. The effect of cocaine and amphetamines on vital signs in trauma patients. The Journal of Emergency Medicine, 13(1): 59-63.


27. Ronco A.M., Urrutia M., Montenegro M., and Llanos M.N., 2009. Cadmium exposure during pregnancy reduces birth weight and increases maternal and foetal glucocorticoids. Toxicology Letters, 188(3): 186-191.


28. Sanchez J., Page J.B., Chitwood D.D., McBride D.C., Kitner K.R., and Comerford M., 2000. First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care, 12(3): 313-320.


29. Satarug S., Baker J.R., Urbenjapol S., Haswell-Elkins M., Reilly P.E., Williams D.J., and Moore M.R., 2003. A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicology Letters, 137(1-2): 65-83.


30. Satarug S., Garrett S.H., Sens M.A., and Sens D.A., 2010. Cadmium, environmental exposure, and health outcomes. Environmental Health Perspectives, 118(2): 182-190.


31. Siegers C.P., Jungblut J.R., Klink F., and Oberheuser F., 1983. Effect of smoking on cadmium and lead concentrations in human amniotic fluid. Toxicology Letters, 19(3): 327-331.


32. Suzuki J., El-Haddad S., 2017. A review: Fentanyl and non-pharmaceutical fentanyls. Drug and Alcohol Dependence, 171: 107-116


33. Thompson P.M., Hayashi K. M., Simon S. L., Geaga J.A., Hong M.S., Sui Y., London E.D., 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience, 24(26): 6028-6036.


34. Unaids W.H.O., 2002. Report on the global HIV. AIDS epidemic.


35. Werf M.J.V.D., Benthem B.H.V., Ameijden E.J.V., 2000. Prevalence, incidence and risk factors of anaemia in HIV‐positive and HIV‐negative drug users. Addiction, 95(3): 383-392.

 White J.M., Dyer K.R., Ali R.L., Gaughwin M.D., Cormack S., 1994.  Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug and Alcohol Dependence, 34(2): 113-119.